Literature DB >> 13201718

The mechanisms by which macrophages phagocyte encapsulated bacteria in the absence of antibody.

W D SAWYER, M R SMITH, W B WOOD.   

Abstract

EVIDENCE HAS BEEN PRESENTED: (1) that macrophages from experimentally produced inflammatory exudates are capable of phagocyting fully encapsulated Type I pneumococci and group A Friedländer's bacilli in the absence of antibody, (2) that the principal mechanisms involved are those of surface phagocytosis, and (3) that the majority of pneumococci ingested by macrophages in antibody-free preparations are ultimately destroyed. The relationship of these phenomena to the mechanism of recovery in pneumococcal and Friedländer's bacillus infections has been briefly discussed.

Entities:  

Keywords:  BACTERIA; MACROPHAGES

Mesh:

Substances:

Year:  1954        PMID: 13201718      PMCID: PMC2136383          DOI: 10.1084/jem.100.4.417

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  9 in total

1.  Relation of Surface Phagocytosis to the Fibrinous Character of Acute Bacterial Exudates.

Authors:  M R Smith; W B Wood
Journal:  Science       Date:  1949-08-19       Impact factor: 47.728

2.  Effect of filter paper, para-hydroxybenzoic acid, and fixed tissue on phagocytosis.

Authors:  E M LERNER; J VICTOR
Journal:  Proc Soc Exp Biol Med       Date:  1952-05

3.  THE PROTECTION OF PATHOGENIC MICROORGANISMS BY LIVING TISSUE CELLS.

Authors:  P Rous; F S Jones
Journal:  J Exp Med       Date:  1916-05-01       Impact factor: 14.307

4.  STUDIES ON THE MECHANISM OF RECOVERY IN PNEUMOCOCCAL PNEUMONIA : IV. THE MECHANISM OF PHAGOCYTOSIS IN THE ABSENCE OF ANTIBODY.

Authors:  W B Wood; M R Smith; B Watson
Journal:  J Exp Med       Date:  1946-09-30       Impact factor: 14.307

5.  The egestion of phagocytized particles by leukocytes.

Authors:  A T WILSON
Journal:  J Exp Med       Date:  1953-10       Impact factor: 14.307

6.  STUDIES ON THE MECHANISM OF RECOVERY IN PNEUMONIA DUE TO FRIEDLANDER'S BACILLUS : I. THE PATHOGENESIS OF EXPERIMENTAL FRIEDLANDER'S BACILLUS PNEUMONIA.

Authors:  L Sale; W B Wood
Journal:  J Exp Med       Date:  1947-08-31       Impact factor: 14.307

7.  Studies on the cellular immunology of acute bacteremia. I. Intravascular leucocytic reaction and surface phagocytosis.

Authors:  W B WOOD; M R SMITH; W D PERRY; J W BERRY
Journal:  J Exp Med       Date:  1951-12-01       Impact factor: 14.307

8.  STUDIES ON THE MECHANISM OF RECOVERY IN PNEUMOCOCCAL PNEUMONIA : II. THE EFFECT OF SULFONAMIDE THERAPY UPON THE PULMONARY LESION OF EXPERIMENTAL PNEUMONIA.

Authors:  W B Wood; E N Irons
Journal:  J Exp Med       Date:  1946-09-30       Impact factor: 14.307

9.  STUDIES ON THE MECHANISM OF RECOVERY IN PNEUMONIA DUE TO FRIEDLADER'S BACILLUS : III. THE ROLE OF "SURFACE PHAGOCYTOSIS" IN THE DESTRUCTION OF THE MICROORGANISMS IN THE LUNG.

Authors:  M R Smith; W B Wood
Journal:  J Exp Med       Date:  1947-08-31       Impact factor: 14.307

  9 in total
  6 in total

1.  Phagocytosis, with particular reference to encapsulated bacteria.

Authors:  W B WOOD
Journal:  Bacteriol Rev       Date:  1960-03

Review 2.  Innate Host Defense against Klebsiella pneumoniae and the Outlook for Development of Immunotherapies.

Authors:  Clement Opoku-Temeng; Natalia Malachowa; Scott D Kobayashi; Frank R DeLeo
Journal:  J Innate Immun       Date:  2021-10-08       Impact factor: 7.111

3.  Surface phagocytosis; further evidence of its destructive action upon fully encapsulated pneumococci in the absence of type-specific antibody.

Authors:  M R SMITH; W B WOOD
Journal:  J Exp Med       Date:  1958-01-01       Impact factor: 14.307

4.  Phagocytosis of bacteria in the absence of antibody and the effect of physical surface; a reinvestigation of surface phagocytosis.

Authors:  E M LERNER
Journal:  J Exp Med       Date:  1956-08-01       Impact factor: 14.307

5.  Studies on the pathogenicity of group A Streptococci. I. Its relation to surface phagocytosis.

Authors:  M J FOLEY; M R SMITH; W B WOOD
Journal:  J Exp Med       Date:  1959-10-01       Impact factor: 14.307

6.  Antibody formation in vitro.

Authors:  M FISHMAN
Journal:  J Exp Med       Date:  1961-12-01       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.